Cargando…

Anti-Androgenic Therapies Targeting the Luminal Androgen Receptor of a Typical Triple-Negative Breast Cancer

SIMPLE SUMMARY: The literature aims to explore anti-androgenic particulars against luminal androgen receptor-specific triple-negative breast cancer, thus providing a concise report on the clinical profile of anti-androgens. This review summarizes the types of triple-negative cancer cells, along with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khadela, Avinash, Chavda, Vivek P., Soni, Shruti, Megha, Kaivalya, Pandya, Aanshi J., Vora, Lalitkumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818775/ https://www.ncbi.nlm.nih.gov/pubmed/36612226 http://dx.doi.org/10.3390/cancers15010233

Ejemplares similares

Contracting triple-negative breast cancer with immunotherapeutic armamentarium: recent advances and clinical prospects
por: Khadela, Avinash, et al.
Publicado: (2022)

mRNA-Based Vaccines and Therapeutics for COVID-19 and Future Pandemics
por: Chavda, Vivek P., et al.
Publicado: (2022)

Phenytoin-induced dyskinesia: a case report
por: Shah, Kashvi C., et al.
Publicado: (2023)

High phosphorylated cyclin-dependent kinase 2 expression indicates poor prognosis of luminal androgen receptor triple-negative breast cancer: pCDK2 in luminal androgen receptor TNBC
por: Jin, Zining, et al.
Publicado: (2022)

Advanced Phytochemical-Based Nanocarrier Systems for the Treatment of Breast Cancer
por: Chavda, Vivek P., et al.
Publicado: (2023)

Anti-tumor activity of BET inhibitors in androgen-receptor-expressing triple-negative breast cancer
por: Park, In Hae, et al.
Publicado: (2019)

AKR1C2 Promotes Metastasis and Regulates the Molecular Features of Luminal Androgen Receptor Subtype in Triple Negative Breast Cancer Cells
por: Li, Songbin, et al.
Publicado: (2022)

Expression and Clinical Significance of Androgen Receptor in Triple-Negative Breast Cancer
por: Asano, Yuka, et al.
Publicado: (2017)

Targeting the androgen receptor in triple-negative breast cancer: current perspectives
por: Mina, Alain, et al.
Publicado: (2017)

Current status of Cancer Nanotheranostics: Emerging strategies for cancer management
por: Chavda, Vivek P, et al.
Publicado: (2023)

Clinical Implications of Androgen-Positive Triple-Negative Breast Cancer
por: Brumec, Maša, et al.
Publicado: (2021)

Response to mTOR and PI3K inhibitors in enzalutamide-resistant luminal androgen receptor triple-negative breast cancer patient-derived xenografts
por: Coussy, Florence, et al.
Publicado: (2020)

Phospho-kinase profile of triple negative breast cancer and androgen receptor signaling
por: Cuenca-López, María D, et al.
Publicado: (2014)

Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer
por: Thakkar, A., et al.
Publicado: (2016)

Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancer
por: Speers, Corey, et al.
Publicado: (2017)

Intranasal vaccines for SARS-CoV-2: From challenges to potential in COVID-19 management
por: Chavda, Vivek P., et al.
Publicado: (2021)

Correlation between Androgen Receptor Expression in Luminal B (HER–2 Negative) Breast Cancer and Disease Outcomes
por: Yang, Fan, et al.
Publicado: (2022)

Prognostic value of androgen receptor in triple negative breast cancer: A meta-analysis
por: Wang, Changjun, et al.
Publicado: (2016)

Androgen receptor positive triple negative breast cancer: Clinicopathologic, prognostic, and predictive features
por: Astvatsaturyan, Kristine, et al.
Publicado: (2018)

Association of androgen receptor expression with glucose metabolic features in triple-negative breast cancer
por: Lee, Reeree, et al.
Publicado: (2022)

Clinicopathological features and androgen receptor expression in triple negative breast cancer at Lagos, Nigeria
por: Haruna, Muibat, et al.
Publicado: (2022)

Androgen Receptor Status in Triple Negative Breast Cancer: Does It Correlate with Clinicopathological Characteristics?
por: Dubrava, Alex L, et al.
Publicado: (2023)

Androgen deprivation therapy sensitizes triple negative breast cancer cells to immune-mediated lysis through androgen receptor independent modulation of osteoprotegerin
por: Kwilas, Anna R., et al.
Publicado: (2016)

Case Report: Response to Immunotherapy and Anti-Androgen Therapy in Male Occult Triple-Negative Breast Cancer
por: Wang, Xin-Hua, et al.
Publicado: (2022)

Androgen receptor-mediated upregulation of quaking affects androgen receptor-related prostate cancer development and anti-androgen receptor therapy
por: Zhang, Keke, et al.
Publicado: (2018)

PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors
por: Lehmann, Brian D, et al.
Publicado: (2014)

Androgens and Androgen Receptor Actions on Bone Health and Disease: From Androgen Deficiency to Androgen Therapy
por: Chen, Jia-Feng, et al.
Publicado: (2019)

Differential requirements of androgen receptor in luminal progenitors during prostate regeneration and tumor initiation
por: Chua, Chee Wai, et al.
Publicado: (2018)

Bipotent Progenitors Do Not Require Androgen Receptor for Luminal Specification during Prostate Organogenesis
por: Shibata, Maho, et al.
Publicado: (2020)

Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy response
por: Thompson, Kevin J, et al.
Publicado: (2022)

Androgen regulation of the androgen receptor coregulators
por: Urbanucci, Alfonso, et al.
Publicado: (2008)

Androgen Receptor Expression in Early Triple-Negative Breast Cancer: Clinical Significance and Prognostic Associations
por: Pistelli, Mirco, et al.
Publicado: (2014)

L1CAM is expressed in triple-negative breast cancers and is inversely correlated with Androgen receptor
por: Doberstein, Kai, et al.
Publicado: (2014)

Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study
por: Bhattarai, Shristi, et al.
Publicado: (2019)

Androgen receptor expression identifies patient with favorable outcome in operable triple negative breast cancer
por: Hu, Xiao-Qing, et al.
Publicado: (2017)

Androgen Receptor mRNA levels determine the prognosis in triple-negative breast cancer patients
por: Govindan, Sindhu, et al.
Publicado: (2020)

Inhalable Vaccines: Can They Help Control Pandemics?
por: Chavda, Vivek P., et al.
Publicado: (2022)

Endoplasmic reticulum stress inhibits AR expression via the PERK/eIF2α/ATF4 pathway in luminal androgen receptor triple-negative breast cancer and prostate cancer
por: Li, Xiaoli, et al.
Publicado: (2022)

Ethnic differences in hepatocellular carcinoma prevalence and therapeutic outcomes
por: Chavda, Vivek, et al.
Publicado: (2023)

Arrabidaea chica chloroform extract modulates estrogen and androgen receptors on luminal breast cancer cells
por: Brandão, Douglas C., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gh2qkkd8hc1ghnlga21nhub27f